Home  »  Stock   »  Pfizer Inc. (PFE) Stock: A Comprehensive 52-Week R...

Pfizer Inc. (PFE) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Pfizer Inc.’s current trading price is -29.46% away from its 52-week high, while its distance from the 52-week low is 7.13%. The stock’s price range over this period has fluctuated between $36.17 and $54.93. The company, operating within the financial sector, had a trading volume of approximately 85.07 million for the day, which was noticeably higher than the average daily share volume of 21.88 million over the last 3 months.

The stock price for Pfizer Inc. (PFE) currently stands at $38.75. The stock experienced a substantial increase in the last session, hitting $38.865 after starting at $36.86. The stock’s lowest price was $36.75 before closing at $36.77.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


In terms of market performance, Pfizer Inc. had a fairly uneven. The highest value for the stock in the past year was $54.93 on 12/14/22, and the lowest value was recorded at $36.17 on 05/18/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Pfizer Inc. (PFE) has experienced a quarterly decline of -9.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 217.03B and boasts a workforce of 83000 employees.

Pfizer Inc.: What Analysts Are Saying

As of right now, 9 analysts are rating Pfizer Inc. as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 12 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 42.08, with a change in price of -12.38. Similarly, Pfizer Inc. recorded 22,911,971 in trading volume during the last 100 days, posting a change of -24.21%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PFE stands at 0.36. Similarly, the long-term debt-to-equity ratio is also 0.31.

PFE Stock Stochastic Average

Today’s raw stochastic average for Pfizer Inc. over the last 50 days is 42.64%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 65.40%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 29.26% and 15.02%, respectively.

PFE Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -24.38%. However, over the past six months, we’ve seen a stronger performance of -19.82%. The price of PFE leaped by -3.63% over the last 30 days. And in the last five days, it has surged by 4.28%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts